10x Genomics (TXG) Cash Flow: Operating & Free Cash Flow

10x Genomics Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for 10x Genomics, Inc. (TXG) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Operating Activities
Net Income	-43.54	-182.63	-255.10	-166.00	-58.22	-542.73	-31.25	-112.49	-18.76
Depreciation & Amortization	43.82	43.71	43.62	33.01	28.25	19.02	7.07	3.91	4.31
Deferred Income Tax	0.00	0.00	0.00	0.00	0.00	1.55	0.61	0.25	0.00
Stock Based Compensation	109.12	140.75	166.95	136.85	95.96	48.63	13.33	2.66	1.66
Change in Working Capital	24.94	1.25	17.34	-39.42	-87.45	-50.38	44.76	28.02	1.95
Change in Accounts Receivable	6.44	26.95	-10.61	-18.95	-34.04	-17.85	-5.28	-14.75	-5.13
Change in Inventory	27.95	-9.78	7.87	-21.19	-30.13	-14.60	-6.70	-3.73	-2.00
Change in Accounts Payable	-2.13	-3.35	-6.02	5.86	11.08	-7.77	4.90	2.59	3.03
Change in Other Working Capital	-10.57	-12.57	0.43	1.96	-7.18	-10.16	51.85	43.91	6.04
Other Operating Activities	1.72	3.58	0.43	1.96	0.08	306.02	0.10	1.25	0.15
Net Cash from Operating Activities	136.05	6.66	-15.20	-33.61	-21.37	-217.90	34.63	-76.41	-10.70
Investing Activities
Capital Expenditures	-5.94	-12.39	-49.52	-131.66	-101.28	-38.39	-42.77	-6.71	-3.76
Acquisitions	-9.27	0.00	0.00	-4.00	-5.45	0.00	0.00	0.00	0.00
Purchases of Investments	-123.44	-48.88	0.00	-282.87	0.00	0.00	0.00	0.00	0.00
Sales/Maturities of Investments	125.20	29.64	183.02	67.65	0.00	0.00	0.00	0.00	0.00
Other Investing Activities	0.00	-1.00	-0.92	0.00	0.00	0.00	0.00	-0.43	0.00
Net Cash from Investing Activities	-13.44	-32.63	133.49	-350.89	-106.73	-38.39	-42.77	-6.71	-3.76
Financing Activities
Debt Repayment	0.00	0.00	-5.81	-5.41	-5.03	-37.10	0.00	18.74	-0.39
Common Stock Issued	6.80	10.91	19.48	21.23	40.33	482.27	410.82	1.80	0.00
Common Stock Repurchased	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.08
Other Financing Activities	0.00	0.00	-5.81	-5.41	-5.03	23.74	3.77	86.63	21.06
Net Cash from Financing Activities	6.80	10.91	13.67	15.82	35.30	468.91	414.59	105.37	20.58
Summary
Effect of Forex Changes on Cash	0.48	-0.16	-0.03	-0.04	0.23	-0.46	-0.05	-0.02	-0.01
Net Change in Cash	129.90	-15.22	131.93	-368.72	-92.57	212.15	406.41	22.23	6.11
Cash at Beginning of Period	344.07	359.28	227.35	596.07	688.64	476.49	70.09	47.86	41.74
Cash at End of Period	473.97	344.07	359.28	227.35	596.07	688.64	476.49	70.09	47.86
Free Cash Flow	130.12	-5.73	-64.72	-165.27	-122.65	-256.29	-8.14	-83.12	-14.46
Supplemental Disclosures
Interest Paid	-	-	0.44	0.84	1.22	-	-	-	-
Income Taxes Paid	2.39	5.64	4.93	3.93	8.66	-	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About 10x Genomics Cash Flow

What is 10x Genomics's free cash flow?

10x Genomics generated free cash flow of $130.12M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $136.05M minus $5.93M of capital expenditures. Free cash flow equaled 20.2% of revenue.

How much does 10x Genomics spend on capital expenditures?

10x Genomics spent $5.93M on capital expenditures in fiscal 2025, compared with $12.39M a year earlier. That equals 4.4% of operating cash flow.

Does 10x Genomics pay dividends or buy back shares?

10x Genomics's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition